top of page


Intelisci Appoints Global Biopharma Executive, Dr. Neil Wishart, to its Scientific Advisory Board
Intelisci, a leading Specialist Retained Search and Advisory firm dedicated to providing essential support to growing biotechnology...
matttongs
Dec 5, 20232 min read


Intelisci Elevates Its Advisory Board with Biopharmaceutical Expert Roberta Duncan
Intelisci, a search firm renowned for its personalized executive search and advisory services for the biotechnology industry, is excited...
matttongs
Nov 19, 20231 min read


Executive Director / VP, Immunobiology
Wilmington, DE. On-site. $325k - $400k + World class Equity program, Relocation and Benefits. Join a world-class biopharmaceutical...
matttongs
Nov 11, 20231 min read


Intelisci LLC Welcomes Rob Drury-Dryden to the Scientific Advisory Board
NY, NY – Intelisci LLC, a specialized executive search and advisory service company in the biopharmaceutical sector, proudly announces...
matttongs
Nov 9, 20232 min read


Senior Medical Director
TREG/Gene Editing. Autoimmune Tx. Forward funded company. Remote role. Intelisci invites MD Rheumatologists or Gastroenterologists to...
matttongs
Oct 24, 20232 min read


Advisory Insights for Biotech Leaders in Transition: A Look at Fierce Bio's October Trackers
The biotech landscape, as reflected in Fierce Bio's layoff and funding trackers for October, presents a duality. While some companies are...
matttongs
Oct 18, 20232 min read
Senior Director, Regulatory Stratergy
Outcome: Secured a Senior Director of Regulatory within a month after the internal team's year-long unsuccessful search. Company Profile:...
matttongs
Sep 6, 20231 min read


Part 3: Key Leaders are tough to find and harder to capture..
Identifying and recruiting leadership and specialist employees specifically for non-viral gene therapy is a unique challenge due to the...
matttongs
Jun 15, 20233 min read


Part 2: Trailblazing Non-Viral Gene Therapy: Navigating Through Hurdles Towards Revolutionary Drugs.
Non-viral gene therapy offers a potentially safer alternative to viral vectors, but it does come with its own unique set of challenges:...
matttongs
Jun 15, 20232 min read


Part 1: Unraveling the Complexity of Gene Therapy: Overcoming Challenges with Non-Viral Delivery.
Gene therapy aims to treat or prevent disease by introducing, altering, or silencing genes within a patient's cells. The "one and done"...
matttongs
Jun 15, 20232 min read


Risky Rewards: How Biotech Firms Leverage Equity for Executive Edge
As competition for top talent continues to intensify in the field of immune-mediated drug development, both large pharmaceutical...
matttongs
Jun 15, 20233 min read


Leadership in the Crucible: Navigating the Search for Executives in Immune-Mediated Drug Development
Finding executive talent, such as C-suite and Vice President (VP) level roles, for the field of immune-mediated drug development adds an...
matttongs
Jun 15, 20232 min read


Navigating the Talent Landscape in Immune-Mediated Drug Development
The field of immune-mediated drug development is a highly competitive and specialized one, requiring skilled professionals across various...
matttongs
Jun 15, 20232 min read


Unleashing the Power of the Immune System: Triumphs and Trials in Immune-Mediated Drug Development
The human immune system is incredibly complex, involving numerous cell types, signaling pathways, and molecular mechanisms. As our...
matttongs
Jun 15, 20232 min read


The Evolution of Immune-Mediated Drug Development: A Journey Through Time
Immunology, the science of the body's defense mechanism, has been a field of study for centuries. However, the advent of immune-mediated...
matttongs
Jun 15, 20232 min read
Senior or Executive Director of Clinical Pharmacology
Our Client is a leading commercial stage Biotechnology company with an exciting portfolio of clinical prospects addressing unmet need in...
matttongs
Jun 7, 20232 min read


🌟 AI. Part 5: Nurturing the AI-Ready Workforce:
Skills Evolution and Talent Acquisition Challenges ⚙️👩💼 As AI continues to reshape the landscape of drug development, it is crucial to...
matttongs
May 24, 20232 min read


⚡ AI. Part 4: Overcoming Challenges: Navigating the Path of AI in Drug Development ⚠️🚧
As we embrace the potential of AI in drug development, it is crucial to address the challenges that lie ahead. Let's delve into key...
matttongs
May 24, 20232 min read


💼 AI. Part 3: Funding the Future:
Uncover emerging funding options tailor-made for startups developing AI-driven approaches. From venture capital to strategic...
matttongs
May 24, 20232 min read


🚀 AI. Part 2: Modalities & Indications:
A focus on the modalities poised to benefit most from AI, from small molecules to gene therapies. Thoughts on how AI is reshaping the...
matttongs
May 24, 20232 min read
bottom of page